Lorenza Rimassa
@LorenzaRimassa
Followers
3K
Following
33K
Media
537
Statuses
11K
Associate Professor of Medical Oncology at HUNIMED, GI cancer specialist with research interest in #livercancer, #HCC, #biliarytractcancer, #cholangiocarcinoma
Milan, Italy
Joined August 2015
RT @hccconnectinfo: Navigating advanced HCC: treatment strategies beyond immunotherapy (IO). Watch the video to explore treatment strategie….
0
6
0
RT @casadei_gardini: Impact of antibiotic therapy in patients with cholangiocarcinoma treated with chemoimmunotherapy.👉 .
karger.com
Abstract. Background: Patients with biliary tract cancers (BTC) often require antibiotic therapy before starting systemic treatment that includes an immune checkpoint inhibitor. This study aims to...
0
4
0
RT @EASLnews: 🌟 Registration and abstract submission now open for the EASL Liver Cancer Summit 2026! 🌟. 🗓️ 22–24 January 2026.📍 Edinburgh,….
0
6
0
RT @EASLnews: EASL is deeply saddened to share the news of the passing of Professor Michael P. Manns (1951–2025). A visionary leader in he….
0
35
0
RT @VJOncology: 🚨 New era in biliary tract cancer (BTC) care. 🔹 FGFR2, IDH1 and HER2 targeted therapies.🔹 Immunotherapy + chemo in 1L setti….
0
2
0
RT @ArndtVogel: Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced HCC or gastric hepatoid carcinoma.@JHepatology .htt….
0
9
0
RT @NEJM: MASLD has become the most common chronic liver disease worldwide. Giovanni Targher, MD, Luca Valenti, MD (@lucavalenti75), and Ch….
0
392
0
RT @myESMO: The latest Diary of an Oncology Leader video is out. In this episode, @DrAngelaLamarca shares her thoughts on resilience, probl….
0
11
0
RT @BCLC_group: The experience of severe AEs in patients under IOs who are admitted into the ICU. A multicenter study in Spain with @martaf….
0
13
0
RT @hccconnectinfo: 📢 #HCC micro learning!. What treatment strategies are available for patients with advanced HCC who are ineligible for #….
0
5
0
RT @ArndtVogel: Proteogenomic profiling predicts outcomes of adjuvant chemotherapy in extrahepatic cholangiocarcinoma.@JHepatology .🔎Post-h….
0
13
0
RT @Vaital73: 💉 DEDICATED TO…. …those who still doubt vaccines, call them “opinions”, or think public health can coexist with disinformatio….
0
1
0
RT @TorzilliGuido: Pleased to announce the release of another scaffold sparing solution for boosting one stage removal of multiple bilobar….
0
15
0
RT @TorzilliGuido: New operations & concepts of oncological radicality, led parenchymal-sparing surgery (scaffold-sparing surgery) to its h….
0
15
0